Amneal Pharmaceutica...
NasdaqGS:AMRX
$ 11,85
$-0,21 (-1,74%)
11,85 $
$-0,21 (-1,74%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,83
Earnings Per Share
$9,59
Revenue Per Share
37,38%
Gross Margin %
$3,78 B
Market Cap
$2,57 B
Long-Term Debt
Earnings Per Share
$0,83
Revenue Per Share
$9,59
Gross Margin %
37,38%
Market Cap
$3,78 B
Long-Term Debt
$2,57 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $0,83 $0,58 $0,64 $0,68 $0,85 $0,63 $0,35 $0,98
Earnings Earnings $261,14M $179,78M $196,49M $103,02M $127,01M $93,05M $51,49M $125,20M
RPS Revenue Per Share $0,00 $9,59 $9,01 $7,80 $14,60 $14,01 $13,49 $11,06 $14,57
Revenue Revenue $0,00M $3,02B $2,79B $2,39B $2,21B $2,09B $1,99B $1,63B $1,86B
OCF Operating Cash Flow $0,00M $336,14M $295,10M $345,58M $65,10M $241,82M $379,00M $1,71M $250,23M
FCF Free Cash Flow $0,00M $346,37M $243,18M $310,75M $18,69M $194,09M $322,56M $-45,48M $167,14M
OM Operating Margin 0,00% 13,94% 12,47% 11,34% 9,04% 10,35% 7,31% -0,78% 17,19%
GM % Gross Margin % 0,00% 37,38% 36,35% 36,09% 35,78% 37,44% 32,74% 28,59% 42,57%
FCFS Free Cash Flow Per Share $0,00 $0,72 $0,71 $1,57 $-0,17 $1,27 $2,12 $-0,72 $1,20
LT Debt Long-Term Debt N/A $2,57B $2,16B $2,43B $2,63B $2,73B $2,83B $2,61B $2,63B
Sha. Stocks 314,63M 314,63M 309,97M 307,01M 151,5M 149,42M 147,7M 147,11M 127,75M
×